BMS partners with Sensyne Health for rare blood disease research
Collaboration will involve applying machine learning for research into rare blood diseases
Read More
Tag: Rare blood disease
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
